You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.
Asia leads in bispecific ADCs
Text:
Hanna Norrlid | [email protected]
Bispecific antibody drug conjugates represent a new and promising development in targeted cancer therapy. The technology combines the precision of monoclonal antibodies with the power of cytotoxic drugs. Although the treatment concept is still in its...